In a clinical trial, the random allocation (randomization) of the treatment evaluated is intended to:
Form comparable groups based on potential confounding factors
Conclude a difference with a statistical significance threshold of 5%
Mitigating Sampling Fluctuations
Keep subjects unaware of the treatment allocated for the entire study period
Reduce the number of topics needed